Mens Health
Natural health product licensed in Canada
- Other names
- Physicians Research, Physicians Research Mens Health
- Licence holder
- Natural Professional Therapeutics Inc.
- NPN or DIN-HM
- 80041225
- Status
- Active licence
- Licence date
- 22 March 2013
- Revision date
- 24 February 2014
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lepidium meyenii Source : Racine Extract : Extract Type TBA Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 milligramme | Not calculated |
| Prunus africana Source : Écorce de racine Extraction ratio : 30:1 Dry plant equivalent : 1,500 mg | 50 milligramme | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 220 milligramme | Not calculated |
| Eurycoma longifolia Source : Écorce de racine Extraction ratio : 100:1 Dry plant equivalent : 5,000 mg Potency : 40 Pour cent Glycosaponins | 50 milligramme | Not calculated |
| Eurycoma longifolia Source : Écorce de racine Potency : 22 Pour cent Eurypeptides | Not specified | Not calculated |
| Eurycoma longifolia Source : Racine Extraction ratio : 100:1 Dry plant equivalent : 5,000 mg Potency : 40 Pour cent Glycosaponins | 50 milligramme | Not calculated |
| Eurycoma longifolia Source : Racine Potency : 22 Pour cent Eurypeptides | Not specified | Not calculated |
| Eurycoma longifolia Source : Écorce (branche) Extraction ratio : 100:1 Dry plant equivalent : 5,000 mg Potency : 40 Pour cent Glycosaponins | 50 milligramme | Not calculated |
| Eurycoma longifolia Source : Écorce (branche) Potency : 22 Pour cent Eurypeptides | Not specified | Not calculated |
| Zinc Source : Diglycinate de zinc | 5 milligramme | 10,000 µg |
| Serenoa repens Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 1,600 mg Potency : 85 Pour cent Free fatty acids, esters, and sterols | 160 milligramme | Not calculated |
| Urtica dioica Source : Feuille Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 milligramme | Not calculated |
| Panax ginseng Source : Racine Extraction ratio : 20:1 Dry plant equivalent : 600 mg Potency : 80 Pour cent Total ginsenosides | 30 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Cellulose, Hypromellose, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1 Capsule | minimum: 2 days ; maximum: 2 days |
Uses authorised in Canada
Men¿s Health is used in Herbal Medicine to help relieve the urologic symptoms associated with mild benign prostatic hyperplasia. Men¿s Health helps to maintain immune function and is a factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
According to TCM, do not use in cases of yin deficiency with heat signs, heat excess, or in absence of significant qi deficiency. Children under the age of 18 years should not use this product.
- Effets indésirables connus
Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. Some people may experience gastrointestinal discomfort (such as diarrhea).
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Do not use if you have had a heart attack/myocardial infarction. Consult a health care practitioner prior to use to exclude a diagnosis of prostate cancer. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking antidepressant medication, high blood pressure medication or seizures. Consult a health care practitioner prior to use if you are taking health products that affect blood coagulation (ie. blood thinners, digoxin, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase risk of spontaneous bleeding. Consult a health care practitioner prior to use if you are taking medication for cardiovascular diseases and/or erectile dysfunction. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult a health care practitioner prior to use if you have a renal kidney disease or if you are following a low protein diet. Consult a health care practitioner prior to use if you have a history of mental/neurological conditions, or hormone sensitive conditions. Consult a health care practitioner prior to use if you have been diagnosed with hypoactive sexual disorder, sexual dysfunction or erectile dysfunction. Consult a health care practitioner prior to use if you suffer from any psychological disorder and/or condition such as frequent anxiety or depression.
Source
Official Health Canada record, licence 80041225
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging